Literature DB >> 26182399

Synchronous occurrence of early neuroendocrine carcinoma and tubular adenocarcinoma in the stomach.

Yoshifumi Nakayama1,2, Aiichirou Higure3, Kazunori Shibao3, Nagahiro Sato3,4, Nobutaka Matayoshi3, Koji Yamaguchi3.   

Abstract

This report describes a patient with early neuroendocrine carcinoma (NEC) and tubular adenocarcinoma in the stomach. A 74-year-old Japanese male experienced epigastralgia. Endoscopic examination revealed two small lesions; one was an elevated lesion with ulceration at the posterior wall of the pre-pylorus and the other was a depressed lesion at the greater curvature of the antrum. Pathological diagnosis of the biopsies indicated poorly differentiated adenocarcinoma from the lesion on the pre-pylorus and well differentiated adenocarcinoma from the lesion on the antrum. He was referred to the surgical outpatient clinic with early double cancer of the stomach. A distal partial gastrectomy with lymph node dissection was performed. A histopathological examination revealed NEC at the lesion on the pre-pylorus and well differentiated tubular adenocarcinoma at the lesion on the antrum. These two lesions were completely separate from each other. Therefore, this case is thought to demonstrate the synchronous occurrence of early NEC and tubular adenocarcinoma in the stomach.

Entities:  

Keywords:  Early gastric cancer; Neuroendocrine carcinoma; Stomach; Synchronous; Tubular adenocarcinoma

Year:  2012        PMID: 26182399     DOI: 10.1007/s12328-012-0320-7

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  23 in total

1.  Oat-cell carcinoma of the stomach.

Authors:  T Matsusaka; H Watanabe; M Enjoji
Journal:  Fukuoka Igaku Zasshi       Date:  1976-02

2.  Extrapulmonary small cell gastric carcinoma. A case report and review of the literature.

Authors:  K J O'Byrne; A K Cherukuri; M I Khan; R J Farrell; P A Daly; E C Sweeney; P W Keeling
Journal:  Acta Oncol       Date:  1997       Impact factor: 4.089

Review 3.  Early gastric cancer of the small cell type.

Authors:  T Fukuda; Y Ohnishi; T Nishimaki; H Ohtani; S Tachikawa
Journal:  Am J Gastroenterol       Date:  1988-10       Impact factor: 10.864

4.  Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.

Authors:  Sayaka Onoda; Noriyuki Masuda; Takashi Seto; Kenji Eguchi; Yuichi Takiguchi; Hiroshi Isobe; Hiroaki Okamoto; Takashi Ogura; Akira Yokoyama; Nobuhiko Seki; Yoshiko Asaka-Amano; Masao Harada; Akihiro Tagawa; Hiroshi Kunikane; Masanori Yokoba; Kazutsugu Uematsu; Takayuki Kuriyama; Yumi Kuroiwa; Koshiro Watanabe
Journal:  J Clin Oncol       Date:  2006-12-01       Impact factor: 44.544

5.  Gastric carcinoid and gastric carcinoma. Morphologic correlates of survival.

Authors:  L W Rogers; R C Murphy
Journal:  Am J Surg Pathol       Date:  1979-06       Impact factor: 6.394

6.  Advanced gastric endocrine cell carcinoma with distant lymph node metastasis: a case report and clinicopathological characteristics of the disease.

Authors:  Naokazu Chiba; Tatsushi Suwa; Masao Hori; Masayoshi Sakuma; Masaki Kitajima
Journal:  Gastric Cancer       Date:  2004       Impact factor: 7.370

7.  Two cases of primary small cell carcinoma of the stomach.

Authors:  Masaya Iwamuro; Shouichi Tanaka; Akihiro Bessho; Hideaki Takahashi; Takeyuki Ohta; Rie Takada; Ichiro Murakami
Journal:  Acta Med Okayama       Date:  2009-10       Impact factor: 0.892

8.  Adenocarcinoma and atypical carcinoid: morphological study of a gastric collision-type tumour in the carcinoma-carcinoid spectrum.

Authors:  A Corsi; C Bosman
Journal:  Ital J Gastroenterol       Date:  1995 Jul-Aug

9.  Concurrent occurrence of adenocarcinoma and carcinoid tumor in the stomach: a composite tumor or collision tumors?

Authors:  M Yamashina; R A Flinner
Journal:  Am J Clin Pathol       Date:  1985-02       Impact factor: 2.493

10.  A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer.

Authors:  E F Smit; E Fokkema; B Biesma; H J Groen; W Snoek; P E Postmus
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

View more
  4 in total

1.  Gastric adenocarcinoma is concurrent with metastatic neuroendocrine cancer treated with nivolumab and chemotherapy: A case report.

Authors:  Bing Yan; Meiqi Cui; Junhao You; Fang Li; Hui Liu
Journal:  Mol Clin Oncol       Date:  2018-10-05

2.  The Significant Influence of the Neuroendocrine Component on the Survival of Patients with Gastric Carcinoma Characterized by Coexisting Exocrine and Neuroendocrine Components.

Authors:  Hu Ren; Su-Sheng Shi; Nian-Chang Wang; Xing Wang; Ying-Tai Chen; Dong-Bing Zhao
Journal:  J Oncol       Date:  2019-03-12       Impact factor: 4.375

3.  Neuroendocrine neoplasms of gastrointestinal tract and secondary primary synchronous tumors: A systematic review of case reports. Casualty or causality?

Authors:  Rafael Parra-Medina; Paula Moreno-Lucero; Julian Jimenez-Moreno; Alejandra María Parra-Morales; Alfredo Romero-Rojas
Journal:  PLoS One       Date:  2019-05-14       Impact factor: 3.240

4.  Clinical characteristics of early neuroendocrine carcinoma in stomach: A case report and review of literature.

Authors:  Xiaolong Zhu; Haiyan Jing; Takashi Yao
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.